No phaseRecruiting

Efficacy of Human Placental Membrane Products and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers (BIORESCUE)

A Multicenter, Prospective, Controlled Modified Multi-Platform Trial Assessing the Efficacy of Human Placental Membrane Products and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers

Sponsor
BioLab Holdings (Industry)
Enrolment
50 planned
Conditions
Diabetic Foot Ulcer; Foot Ulcer Chronic; DFU; Ulcer Foot; Venous Leg Ulcer (VLU); Venous Leg Ulcer; Venous Ulcer; Leg Ulcers; Ulcer
Interventions
Tri-Membrane Wrap™ DFU; Membrane Wrap™ DFU; Membrane Wrap-Lite™ DFU; Membrane Wrap-Hydro™ DFU; Tri-Membrane Wrap™ VLU; Membrane Wrap™ VLU; Membrane Wrap-Lite™ VLU; Membrane Wrap-Hydro™ VLU
Ages
adults, older adults
Registry
NCT07364630

Full record on ClinicalTrials.gov

From the registry

The study is a multicenter, prospective, controlled modified multi-platform trial assessing the efficacy of human placental membrane products and standard of care in the management of nonhealing diabetic foot ulcers and venous leg ulcers.

Primary outcomes

  • Percentage of Wound Closure

History

  1. Primary completion expected

  2. Last registry update

  3. Registered

  4. Started